Cargando…
Development of the B cell cancer vaccine HER-vaxx for the treatment of her-2 expressing cancers
Her-2/neu is a tumor-associated protein that is overexpressed in a number of malignancies, including advanced cancer of the stomach, and has been proposed as a human cancer vaccine target. Overexpression of Her-2/neu in human breast and gastric carcinomas correlates with a more aggressive course of...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791928/ https://www.ncbi.nlm.nih.gov/pubmed/36578947 http://dx.doi.org/10.3389/fonc.2022.939356 |